Innovations In Clinical Neuroscience

Pain Management August 2016

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link:

Contents of this Issue


Page 22 of 35

Hot Topics in Pain Management [August 2016] 23 Further, it would be helpful to become familiarized with the AGREE II instrument domains to know what information should be reported and how it ought to be reported in the CPGs. Here, we also give some pointers to reduce the variability among the CPGs: 1. The study should describe the specific health question it aims to address, such as prevention, screening, diagnosis, or treatment, and target population, including sex, age clinical condition, severity stage of the disease, comorbidities, and others. 2. The guideline development group should include individuals from all relevant professional groups, not only or mainly health care providers. Competing interests of guideline development group members should be fully recorded and addressed. 3. In the guideline development process, appropriate methodologies and rigorous strategies are important for successful implementation of the resulting recommendations, such as the systematic methods and criteria for selecting the evidence, methods for formulating the recommendations, health benefits, side effects considered in formulating the recommendations, links between

Articles in this issue

Archives of this issue

view archives of Innovations In Clinical Neuroscience - Pain Management August 2016